AI assistant
Sending…
Tharimmune, Inc. — Director's Dealing 2025
Aug 6, 2025
34824_dirs_2025-08-06_d556220a-b8cf-45d4-a465-ba02673a49a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Tharimmune, Inc. (THAR)
CIK: 0001861657
Period of Report: 2025-08-04
Reporting Person: Appajosyula Sireesh (Director, CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-04 | Stock Option | $1.33 | A | 90000 | Acquired | 2035-08-04 | Common Stock (90000) | Direct |
Footnotes
F1: 45,000 of the stock options vest on date of grant and 45,000 vest on August 4, 2026.
More from Tharimmune, Inc.
Interim / Quarterly Report
2026
May 13
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 3
Regulatory Filings
2026
Mar 3
Regulatory Filings
2026
Feb 18
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11